Apixaban outmatches rivaroxaban for VTE in study.(VENOUS THROMBOEMBOLISM)

  • Colleen Edwards

Press/Media

Period1 Jan 2022

Media coverage

1

Media coverage

  • TitleApixaban outmatches rivaroxaban for VTE in study.(VENOUS THROMBOEMBOLISM)
    Media name/outletInternal Medicine News
    Country/TerritoryUnited States
    Date1/01/22
    PersonsColleen Edwards
View all 1
View less